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The major mono- and disialogangliosides of the extensively characterized established human glioma line 
D54MG were isolated and purified from subcutaneous olid xenografts grown in athymic (nu/nu) mice. 
Structural determination showed that they belonged to the lactotetraosylceramide s ries. The sialyllacto- 
tetraosylceramide contained 90% N-glycolyl- and 10% N-acetylneuraminic acid linked in an ~2-3 linkage 
(IV3NeuGc-~Ose~Cer, IV3Ne~c-~O~~Cer). The disia~ogangliosides had a previously undescribed type 
of structure with sialic acids linked to the terminal galactose inan a2-3 linkage and to N-acetylglucosamine 
in an a2-6 linkage. Not only did species with NeuAc or NeuGc occur, but also species with mixtures of 
the two sialic acids, e.g. NeuAC and NeuGc. The schematic structures of the new disialogangliosides are 
Gal/31 * 3GlcNAcBl -3Ga1/31+4Glc-&er 
ot2t3 ct2t6 
(NeuAc, NeuGc) (NeuAc, NeuGc) 
Tumor ganglioside Gl~o~a-assaciated ganglioside ~0nosiaIogungiiosi~ 
Lactotetraose series 
1. INTRODUCTION 
Neoplastic transformation of cells is accom- 
panied by alteration of the ganglioside pattern [l] 
and quantitative or qualitatively distinctive tumor- 
associated gangliosides often appear. These 
gangliosides are suitable as immunogens for the 
production of specific antibodies with reactivities 
against tumor cells [2]. 
Primary brain tumors, which are often highly in- 
filtrative lesions with ill-defined borders relative to 
normal brain, pose particular problems with 
regard to the isolation of their gangliosides. In 
malignant glioma tissue, tumor cell-associated 
gangliosides are often minor components because 
of the large number and amount of normal brain 
gangliosides that contaminate the infiltrative 
glioma tissue. Established glioma cell lines might 
therefore be a more suitable source for the isola- 
tion of pure tumor-associated gangliosides. In the 
present study we have determined the structure of 
the following glycolipids isolated from D54MG [3] 
murine xenografts: (i) the major monosialogan- 
glioside; (ii) its corresponding neutral glycolipid; 
and (iii) its major disialoganglioside. The back- 
bone structure of the monosialoganglioside is 
lactotetraosylceramide to which N-glycolyl- or N- 
acetylneuraminic acid is bound in an &--3 linkage. 
The major disialoganglioside is also a lacto- 
tetraosylceramide to which sialic acid is bound to 
the terminal galactose in an (~2-3 linkage and to N- 
acetylglucosamine in an a2-6 linkage. To our 
knowledge this is the first time disialogangliosides 
with such a structure have been described. 
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2. MATERIALS AND METHODS 
2.1. Materials 
D54MG is the Duke University subline of A172, 
a permanent cell line originally established from a 
human glioblastoma multiforme [4]. This line was 
established as a serially transplantable glioma line 
in Balb-c nu/nu athymic mice. Its growth, 
characteristics, morphology, karyotype and reac- 
tivity with intracellular, surface, and extracellular 
matrix monoclonal and polyclonal antibodies have 
been extensively described [3,5]. Tumors were 
harvested by removal of the subcutaneous tumors 
and immediate freezing by immersion in liquid 
nitrogen. Gangliosides and neutral glycolipids used 
as standards and references were all isolated at the 
Department of Psychiatry and Neurochemistry, 
Gothenburg University, Sweden. 
2.2. Isolation of gangliosides 
Neutral glycolipids, and mono- and disialo- 
gangliosides were extracted from 130 g tumor 
tissue and separated by anion-exchange chro- 
matography as in [6,7]. Individual glycolipids were 
isolated by preparative thin-layer chromatography 
(TLC) on HPTLC plates. 
2.3. Analytical methods 
Ganglioside sialic acid was determined with the 
resorcinol assay [8]. N-Acetyl- and N- 
glycolylneuraminic acids were analysed by gas- 
liquid chromatography (GLC) as the trimethylsilyl 
derivative of the methyl ester methyl glycoside [9]. 
Sphingosine was assayed by a modification of the 
methyl orange method of Lauter and Trams [lo]. 
The quantitative composition of the carbohydrate 
moiety was determined as alditol acetates by GLC 
[ll]. Hydrolysis with Vibrio cholerae (EC 
3.2.1.18, Behringwerke, Marburg-Lahn, FRG) 
sialidase was performed in 0.01 M Tris-maleate 
buffer (pH 6.5) containing 4 mM CaClz, with or 
without 0.5% (w/v) Triton X-100. 
Permethylation of the gangliosides and neutral 
glycolipids and analyses of the partially methylated 
alditol acetates were carried out as described by 
Mansson et al. [ 121. Fast atom bombardment-mass 
spectrometry (FAB-MS) was performed on a 
VG 7070E mass spectrometer equipped with a fast 
atom gun. The permethylated samples were 
dissolved in chloroform-methanol (1: 5, v/v) to 
110 
give a concentration of 5 nmol/pl. The stainless- 
steel target was coated with one drop of 
thioglycerol-glycerol (1: 1, v/v) [ 131 or thioglycerol 
[ 141. A solution of the permethylated sample (1 pl) 
was then added to the target. The target was bom- 
barded with xenon atoms having kinetic energy 
equivalent o -8 keV. Spectra were recorded in the 
positive ion mode by downfield mass controlled 
linear scans of 100-300 s duration. The resolution 
of the instrument was set to 300 ppm. In the mass 
range 300-800 amu the matrix derived back- 
ground was subtracted. 
3. RESULTS AND DISCUSSION 
The D54MG tumor grown in nude mice con- 
tained 170 nmol ganglioside sialic acid per g wet wt 
tissue, of which 2/3 was in the mono- and l/3 in 
the oligosialoganglioside fraction. Fig. 1 shows the 
thin-layer chromatogram of the two ganglioside 
fractions separated in an alkaline solvent. The ma- 
jor band was approx. 80% of the total 
monosialoganglioside fraction and the major band 
in the oligosialoganglioside fraction approx. 70%. 
The central regions of these two ganglioside bands 
and the fastest migrating oligosialoganglioside 
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Fig. 1. Thin-layer chromatographic separation of 
gangliosides from D54MG murine xenografts. Isolation 
and separation of the gangliosides are described in 
section 2. Chromatographic solvent was chloro- 
form/methanol/2.5 M aqueous NH3 (50:40: 10, by 
vol.). The arrows indicate the ganglioside bands 
subjected to structural analyses. (1) Monosialo- and (2) 
oligosialoganglioside fraction. 
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(fraction 2, fig.1) were subjected to structural 
analyses. 
The isolated monosialo~~~ioside contained 
sphingosine, sialic acid, glucose, galactose and N- 
acetylglucosamine in a molar ratio of 1: 1: 1 : 2 : 1. 
The ratio between Wglycolylneuraminic acid and 
N-acetylneuraminic acid was 9 : 1. Hydrolysis with 
sialidase or weak acid yielded a tetraglycosyl- 
ceramide with TLC migration similar to that of 
globotetraosylcer~ide. Prolonged acid hydrolysis 
produced compounds with the same mobility on 
TLC as lactosylceramide and glucosylceramide 
with long-chain (C22-C24) fatty acids. The results 
of the permethylation analysis of the intact mono- 
The FAB mass spectra of the permethylated 
ganglioside (fig.2) showed ions at m/z 406 and 374 
(406 - 32) indicating ~-glycolylneuraminic acid, 
and at m/z 376 and 344 (376 - 32) indicating N- 
acetylneuraminic acid. Sequence ions at m/z 855 
and 1059 represent NeuGc-Hex-HexNAc and 
NeuGc-Hex-HexNAc-Hex, and at m/z 825 and 
Tabie 1 
sialoganglioside are shown in table 1. The finding 
of 4,6-Me2-GlcNAcMe as the only amino sugar 
showed that the ganglioside belonged to the lac- 
totetraose series. The appearance of 2,3,4,6-Me4- 
Gal, in the desialylated compound suggests that 
the sialic acid was linked ~2-3 to terminal 
galactose. 
Results of the permethylation analyses of D54MG murine xenograft gangliosides and neutral glycolipids 
Monosialo- 
ganglioside 
Desialylated 
monosialo- 
ganglioside 
Disialo- 
ganglioside 
fraction 1 
Disialo- 
ganglioside 
fraction 2 
Neutral 
glycoIipid 
fraction 
2,3,6-Me3-Glc 1.00 1.00 1.00 1.00 1.00 
2,3,4,6-Me&al 0.93 - 0.32 
2,4,6-Mes-Gal 2.03 0.93 1.69 1.45 0.90 
2,3,6-Mes-Gal - - 0.31 
2,6-Mez-Gal - - 0.53 
3,4,6-Mew-GaINA~Me - - - 0.55 
4,6-Mez-GalNAcMe - - 0.36 
4,6-Mez-GlcNAcMe 0.88 0.83 _ 0.36 
4-Me-GlcNAcMe 0.71 0.51 
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Fig.2. Positive ion FAB-MS of the permethylated monosialoganglioside. The matrix derived background was subtracted 
in the mass range 300-800 amu. 
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1029 the corresponding fragments containing 
NeuAc. The ceramide portion was represented 
mainly by ions at m/z 660, which corresponds to 
CZ~:O fatty acid and 4-sphingenine. 
In the molecular ion region the ion at m/z 1940 
(M + H) corresponds to NeuGc-Hex3-HexNAc-Cer 
with CU:O fatty acid and 4-sphingenine. A small 
ion at m/z 1910 represents the NeuAc-containing 
ganglioside. The FAB mass spectra of the 
permethylated desialylated compound (fig.3) 
showed a dominating molecular ion at m/z 1549 
(M + H) corresponding to HexNAc-Hexj-Cer with 
C24:0 fatty acid. Also, ions with low intensities 
were found at m/z 1535 and 1521, which cor- 
responds to the same carbohydrate composition 
with CZ~:~ and C22:,-, fatty acids. The intense ion at 
m/z 1199 may be derived from M + H - acyl chain 
(1549 - 350). Ions at m/z 464 and 432 (464 - 32) 
correspond to the terminal sequence Hex-HexNAc 
and the ion at m/z 668 to sequence Hex-HexNAc- 
Hex. Ions at m/z 660, 646 and 632 correspond to 
a ceramide portion with c24 to C22 fatty acids with 
4-sphingenine. These results show that the struc- 
ture of the major monosialoganglioside is 
IV3NeuGc-LcOse4Cer (NeuGm2-3Galpl-3Glc- 
NAc@l-3Gal,f31-4Glc+!?l-1Cer). 
Sialidase or weak acid hydrolysis of the two 
oligosialoganglioside fractions 1 and 2 resulted in 
a neutral glycolipid with the same TLC migration 
as that of the glycolipid obtained from the 
z 
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monosialoganglioside. The slower migrating frac- 
tion 2 gave a sialidase-resistant monosialo- 
ganglioside with a migration slightly slower than 
that of GMl. The FAB mass spectra of the faster 
migrating oligosialoganglioside showed a weak ion 
at m/z 2271 (M + H) corresponding to NeuAcz- 
HexJ-HexNAc-Cer with c24:0 fatty acid and 
4-sphingenine, a ceramide composition verified by 
the ions at m/z 1921 (M + H - acyl chain) and 660. 
There were no ions representing a disialyl group. 
However, sequence ions were found at m/z 1186 
and 1390 which correspond to NeuAq-Hex- 
HexNAc and NeuAcz-Hexz-HexNAc, respectively. 
In addition, the analysis of the partially meth- 
ylated alditol acetates (table 1) revealed the occur- 
rence of a disubstituted N-acetylhexosamine 
(CMe-GlcNAcMe). Taken together these findings 
indicate the structure to be IV3NeuAc, II16NeuAc- 
LcOse&er(NeuAccY2-3GaWl-3(NeuAo.z2-6)Glc- 
NAc@l-3Gal,&l-4Glc@l-1Cer). 
The second, slightly slower migrating and major 
oligosialoganglioside fraction gave, on FAB mass 
spectral analysis, a dominating molecular ion at 
m/z 2331 (M + H) corresponding to NeuGs- 
Hexj-HexNAc-Cer with c24:O fatty acid and 
4-sphingenine. In addition, a weak molecular ion 
at m/z 2301 corresponding to NeuAc-NeuGc- 
Hexj-HexNAc-Cer24,o was detected. The relative 
proportion of NeuGc, represented by ions at m/z 
406 and 374, and NeuAc, represented by ions at 
1199 
MASS PER CHARGE 
Fig.3. Positive ion FAB-MS of the permethylated esialylated monosialoganglioside. The matrix derived background 
was subtracted in the mass range 400-800 amu. 
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m/z 376 and 344 was 2: 1. A group of sequence 
ions were found at m/z 1186, 1216, 1246 (the 
dominating one) and 1450 corresponding to 
NeuAcz-HexNAc-Hex, NcttGc-NeuAc-HexNAc- 
Hex, NeuGcz-Hex-HexNAc and NeuGcz-Hexz- 
HexNAc, respectively. Finally, the ion at m/z 855 
revealed the occurrence of NeuGc-Hex-HexNAc. 
Analysis of the partially methylated alditol 
acetates showed 4-Me-GlcNAcMe, 4,6-Mez- 
GalNAcMe and 2,6-Me2-Gal. These results in- 
dicate that the analysed oligosialoganglioside frac- 
tion 2 contained two major structures IV3-cu-SA, 
II16-cY-SA,LcOsedCer and IV3~-SA,I13~-SA, 
GgOsedCer. 
A neutral glycolipid with a TLC migration 
similar to globotetraosylceramide was isolated 
from the solid tumor. It constituted less than 1% 
of the neutral glycolipid fraction. FAB-MS 
analyses showed the major molecular ion at m/z 
1549 which corresponds to Hexs-HexNAc-Cer with 
C&$:0 fatty acid and 4-sphingenine. The ion at m/z 
1199 represents M + H - acyl chain. A terminal 
HexNAc is revealed by the ion at m/z 260, while 
the ions detected at m/z 464 and 668 correspond to 
Hex-HexNAc and Hexs-HexNAc, respectively. 
These results combined with the permethylation 
analyses (table 1) suggest hat the fraction is a mix- 
ture of globotetraosylceramide and lactotetra- 
osylceramide (GalNA@l-3Gakl-4Galpl- 
4Glc@l-1Cer and Gal&-3GlcNAc$l-3Gal@l- 
4Glc,&l-1Cer). 
Our results suggest hat the major gangliosides 
of D54MG solid glioma xenografts grown in nude 
mice belong to the lactotetraosylceramide series. 
C24:0 fatty acid and 4-sphingenine are major com- 
ponents of the ceramide. The sialyllac- 
totetraosylceramide contained 90% N-glycolyl- 
and lOolo N-acetylneuraminic acid. Species of the 
new disialoganglioside with N-acetyl- and N- 
glycolylneuraminic acid only were identified, and 
the mass spectrometric data also indicated species 
with both N-acetyl- and N-glycolylneuraminic 
acid. The schematic structures of the new 
disialogangliosides might then be drawn: 
GaI&l -3GlcNAq31 -3Gal,&l+4Glc-+Cer 
ff2 3 i cr2 6 I 
(NeuAc,NeuGc) (NeuAc,NeuGc) 
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